Login or sign up
For business

Spero therapeutics

3.9Β· 12 reviews
Average ratingAverage
3.9/ 5

Based on 12 reviews

533%
425%
342%
20%
10%
Bryan Underwood
Reviews 1

I recently had an experience with a company that focuses on developing new treatments for antibiotic-resistant bacterial infections. The website provides a clear and informative overview of the company's mission and values. However, I found it slightly challenging to navigate through the site, and the information was not organized as intuitively as I would have liked. The lack of detailed product information was also a drawback for me, as I was seeking more in-depth knowledge about their pipeline. Overall, a decent effort, but there is room for improvement in terms of user-friendliness and accessibility of information.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website β€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Spero therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial infections. Spero’s lead program addresses a novel target driving virulence and persistence of Pseudomonas Aeruginosa infections and other Gram-negative pathogens. The company was founded by Atlas Venture, with financing from SR One and the Partners Innovation Fund.

Address
675 massachusetts avenue
Categories
Biotechnology